Featured Jobs
|
TPA Retirement Plan Consultant EPIC RPS (TPA/DPS)
|
|
New York City District Council of Carpenters Benefit Funds
|
|
Great Lakes Pension Associates, Inc.
|
|
Retirement Solutions Specialists
|
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
|
Greenline Wealth Management
|
|
Retirement Planners and Administrators (RPA)
|
|
Senior Specialist 401k Recordkeeping T Bank N.A.
|
|
Defined Benefit Consultant/Enrolled Actuary Pension Plan Specialists, PC
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
Fringe Benefit Group
|
|
Pollard & Associates
|
|
Defined Contributions Compliance Consultant Loren D. Stark Company (LDSCO)
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
CMS Issues Most Favored Nation Model Interim Final Rule -- What to Expect Next
K&L Gates 
[Guidance Overview] Dec. 4, 2020 "When fully implemented, the new payment model could result in a 65 percent reduction in Part B drug reimbursement. CMS estimates a reduction of $87.8 billion in spending on MFN drugs by the government and $28 billion in beneficiary savings. CMS estimates that, absent price concessions from manufacturers, providers will be underwater on these claims, with some providers, like 340B covered entities, increasing their market share given their favorable purchasing options and ability to purchase drugs with some margin early in the implementation." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |
